Literature DB >> 20476869

Successful control of scleroderma myocarditis using a combination of cyclophosphamide and methylprednisolone.

J Stack, P McLaughlin, C Sinnot, M Henry, P MacEneaney, A Eltahir, S Harney.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2010        PMID： 20476869     DOI： 10.3109/03009740903493741

Source DB:  PubMed          Journal:  Scand J Rheumatol        ISSN： 0300-9742            Impact factor:   3.641


× No keyword cloud information.
  7 in total

Review 1.  Update on assessment and management of primary cardiac involvement in systemic sclerosis.

Authors:  Vasiliki-Kalliopi Bournia; Christos Tountas; Athanase D Protogerou; Stylianos Panopoulos; Sophie Mavrogeni; Petros P Sfikakis
Journal:  J Scleroderma Relat Disord       Date:  2018-04-04

Review 2.  Primary heart involvement in systemic sclerosis, from conventional to innovative targeted therapeutic strategies.

Authors:  Arianna Ferlito; Corrado Campochiaro; Alessandro Tomelleri; Lorenzo Dagna; Giacomo De Luca
Journal:  J Scleroderma Relat Disord       Date:  2022-03-24

3.  Prognostic Role of Ventricular Ectopic Beats in Systemic Sclerosis: A Prospective Cohort Study Shows ECG Indexes Predicting the Worse Outcome.

Authors:  Giacomo De Luca; Silvia Laura Bosello; Francesca Augusta Gabrielli; Giorgia Berardi; Federico Parisi; Manuela Rucco; Giovanni Canestrari; Francesco Loperfido; Leonarda Galiuto; Filippo Crea; Gianfranco Ferraccioli
Journal:  PLoS One       Date:  2016-04-21       Impact factor: 3.240

4.  Silent myocarditis in systemic sclerosis detected by cardiovascular magnetic resonance using Lake Louise criteria.

Authors:  Sophie Mavrogeni; Loukia Koutsogeorgopoulou; Georgia Karabela; Efthymios Stavropoulos; Gikas Katsifis; John Raftakis; Sotiris Plastiras; Michel Noutsias; George Markousis-Mavrogenis; Genovefa Kolovou
Journal:  BMC Cardiovasc Disord       Date:  2017-07-17       Impact factor: 2.298

Review 5.  Sex differences in pulmonary arterial hypertension: role of infection and autoimmunity in the pathogenesis of disease.

Authors:  Kyle A Batton; Christopher O Austin; Katelyn A Bruno; Charles D Burger; Brian P Shapiro; DeLisa Fairweather
Journal:  Biol Sex Differ       Date:  2018-04-18       Impact factor: 5.027

6.  Clinical Outcomes of Myocarditis after Moderate-Dose Steroid Therapy in Systemic Sclerosis: A Pilot Study.

Authors:  Burabha Pussadhamma; Thapanee Tipparot; Naruemol Chaosuwannakit; Ajanee Mahakkanukrauh; Siraphop Suwannaroj; Ratanavadee Nanagara; Chingching Foocharoen
Journal:  Int J Rheumatol       Date:  2020-12-19

Review 7.  Is there still a role for cyclophosphamide in the treatment of systemic sclerosis?

Authors:  Madelon C Vonk
Journal:  J Scleroderma Relat Disord       Date:  2020-10-06
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.